Keeping Track Of Thanksgiving Leftovers: Risdiplam, Artesunate Highlight Glut Of Submissions/Filings

Yes, we know they should be out of the fridge by now, but here are the highlights of submissions and filings during the Thanksgiving week.

Keeping Track Feature image

While a few events, including the US Food and Drug Administration's approval Global Blood Therapeutics Inc.'s sickle cell drug Oxbryta (voxelotor), stole the spotlight in the days leading up to Thanksgiving, sponsors also made a slew of important submission and filing announcements during the short work week.

Genentech Inc. is looking to garner the third FDA approval for a spinal muscular atrophy (SMA) indication after scoring...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA Performance Tracker

More from Regulatory Trackers